Eur Rev Med Pharmacol Sci 2015; 19 (21): 3996-3997

Reply to the Letter “Effect of anti-oxidant agents in patients with hepatocellular diseases”

R. Aller, D.A. de Luis

Svo. Gastroenterology, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain. roaller@yahoo.es

Free PDF Download

To cite this article

R. Aller, D.A. de Luis
Reply to the Letter “Effect of anti-oxidant agents in patients with hepatocellular diseases”

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 21
Pages: 3996-3997

Keywords Related articles:

  1. Effect of anti-oxidant agents in patients with hepatocellular diseases
  2. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database
  3. New biological agents for the treatment of the “high risk” IBD patients
  4. Anti-oxidant activity with inhibition of osteoclastogenesis by Atractylodes Rhizoma extract
  5. Diagnosis accuracy of serum Glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysis